Article
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.
Nature communications - 12 Sept 2023
Tran Norman, Dasari Sathish, Barwell Sarah A E, McLeod Matthew J, Kalyaanamoorthy Subha, Holyoak Todd, Ganesan Aravindhan
Abstract excerpt
The main protease of SARS-CoV-2 (Mpro) is an important target for developing COVID-19 therapeutics. Recent work has highlighted Mpro's susceptibility to undergo redox-associated conformational changes in response to cellular and immune-system-induced oxidation. Despite structural evidence indicating large-scale rearrangements upon oxidation, the mechanisms of conformational change and its functional consequences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
